412 related articles for article (PubMed ID: 24333019)
1. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
Parrott AC; Sands HR; Jones L; Clow A; Evans P; Downey LA; Stalder T
Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
[TBL] [Abstract][Full Text] [Related]
2. MDMA, cortisol, and heightened stress in recreational ecstasy users.
Parrott AC; Montgomery C; Wetherell MA; Downey LA; Stough C; Scholey AB
Behav Pharmacol; 2014 Sep; 25(5-6):458-72. PubMed ID: 25014666
[TBL] [Abstract][Full Text] [Related]
3. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
Downey LA; Sands H; Jones L; Clow A; Evans P; Stalder T; Parrott AC
Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
[TBL] [Abstract][Full Text] [Related]
4. Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users.
Parrott AC
Neuropsychobiology; 2009; 60(3-4):148-58. PubMed ID: 19893332
[TBL] [Abstract][Full Text] [Related]
5. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
6. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
[TBL] [Abstract][Full Text] [Related]
7. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
Parrott AC; Milani RM; Parmar R; Turner JD
Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational 'ecstasy'.
Parrott AC
Behav Pharmacol; 2016 Dec; 27(8):649-658. PubMed ID: 27681116
[TBL] [Abstract][Full Text] [Related]
9. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
Morgan MJ
Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
[TBL] [Abstract][Full Text] [Related]
10. Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
Wetherell MA; Montgomery C
Psychopharmacology (Berl); 2014 Apr; 231(7):1365-75. PubMed ID: 24190587
[TBL] [Abstract][Full Text] [Related]
11. Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.
Parrott AC; Rodgers J; Buchanan T; Ling J; Heffernan T; Scholey AB
Hum Psychopharmacol; 2006 Jul; 21(5):285-98. PubMed ID: 16856221
[TBL] [Abstract][Full Text] [Related]
12. Greater sexual risk-taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study.
May AL; Parrott AC
Hum Psychopharmacol; 2015 Jul; 30(4):272-5. PubMed ID: 26216562
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
Back-Madruga C; Boone KB; Chang L; Grob CS; Lee A; Nations H; Poland RE
Clin Neuropsychol; 2003 Nov; 17(4):446-59. PubMed ID: 15168910
[TBL] [Abstract][Full Text] [Related]
14. Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes.
Parrott AC; Lock J; Conner AC; Kissling C; Thome J
Neuropsychobiology; 2008; 57(4):165-80. PubMed ID: 18654086
[TBL] [Abstract][Full Text] [Related]
15. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
16. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
Parrott AC; Buchanan T; Scholey AB; Heffernan T; Ling J; Rodgers J
Hum Psychopharmacol; 2002 Aug; 17(6):309-12. PubMed ID: 12404677
[TBL] [Abstract][Full Text] [Related]
17. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
Parrott AC; Sisk E; Turner JJ
Drug Alcohol Depend; 2000 Jul; 60(1):105-10. PubMed ID: 10821995
[TBL] [Abstract][Full Text] [Related]
18. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
19. The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.
Davis AK; Rosenberg H
J Psychoactive Drugs; 2014; 46(2):154-61. PubMed ID: 25052792
[TBL] [Abstract][Full Text] [Related]
20. Evidence for executive deficits among users of MDMA (Ecstasy).
Fisk JE; Montgomery C; Murphy P; Wareing M
Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
